Herbalife in agreement to acquire certain assets from Bioniq

The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions and regulatory approvals

Herbalife announced an agreement to acquire certain assets from Bioniq, a UK-based personalised supplements company focused on making health more accessible and actionable.

“The future of health and wellness is becoming more personalised and informed by data,” said Herbalife Chief Executive Officer, Stephan Gratziani. “By combining Bioniq’s personalised supplement technology with Pro2col and the power of our global distributor network, we are expanding our ability to deliver personalized wellness at global scale.”

Bioniq develops personalised supplement formulas using its patented product personalization engine, an individual’s health background, and a proprietary database of biomarkers. Bioniq’s personalised supplement formulations are designed for a broad range of individuals, from everyday wellness consumers to elite athletes, including Cristiano Ronaldo.

“I founded Bioniq in 2019 with a vision to help people optimize their wellbeing through a science-driven approach to nutrition that incorporates biomarker and lifestyle data,” said Vadim Fedotov, Founder and President, Bioniq. “I am excited to join Herbalife with its global distributor network and commitment to advancing wellness at scale.”

The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions and regulatory approvals. The $55 million purchase price will be paid over five years, including an initial payment of $10 million at closing. In addition, the transaction value includes up to $95 million of contingent payments based on future performance.